Status:
COMPLETED
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
Lead Sponsor:
Tuscaloosa Research & Education Advancement Corporation
Collaborating Sponsors:
Janssen, LP
Conditions:
PTSD
Post-Traumatic Stress Disorder
Eligibility:
All Genders
19+ years
Brief Summary
The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on a...
Detailed Description
This study is a retrospective electronic review of the VISN 7 Data Warehouse to determine what have been the emerging trends in prescriptions of atypical antipsychotic medications over the past seven ...
Eligibility Criteria
Inclusion
- Male or female patients, any race or ethnic origin at least 19 years of age.
- Patients with a diagnosis of PTSD
- Treated with an antipsychotic as a monotherapy or adjunctive therapy
- Patient must have been seen at a VA medical center or clinic within VISN 7 during the study period.
Exclusion
- Patients not diagnosed with PTSD
- Not treated with an antipsychotic as a monotherapy or adjunctive therapy
- Patients outside of Network 7
- Patients with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2005
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00230893
Start Date
July 1 2005
End Date
September 1 2005
Last Update
September 21 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, United States, 35404